PTAB judges case unnerves some in-house counsel but leaves others unworried While some businesses are watching Arthrex developments with bated breath, others believe it will have less impact – after the finding that PTAB judges are not constitutionally appointed By Patrick Wingrove January 31 2020
Broad CRISPR loss shows how not to file a priority claim Life sciences in-house sources stress the importance of following the EPO’s strict priority claims guidelines after the Board of Appeal invalidated some of the Broad Institute’s CRISPR patents By Charlotte Kilpatrick January 30 2020
Kings of Europe: why do the 'big four' dominate IP? As France, Germany, the Netherlands and the UK are generally considered Europe’s IP ‘powerhouses’, Managing IP asks why and considers whether similar-sized jurisdictions can compete By Max Walters January 29 2020
IP Australia interview: the shift towards digital intelligence Chief legal counsel Elizabeth Carroll shares views on the organisation’s most innovative developments, the phase-out of innovation patents and what can be expected in the coming 12 months By Karry Lai January 29 2020
High employee turnover creates trade secrets concerns for auto industry Faced with heavy employee churn, sources from the connected car and automotive supply industries reveal ways to keep trade secrets just that By Charlotte Kilpatrick January 27 2020
Building toy towers sets foundation for boosting IP value Counsel at Thyssenkrupp, Visteon, and a fintech and biotech company share their advice for communicating the value of IP to their C-suite By Charlotte Kilpatrick January 23 2020
Philippines: IPOPHL posts proposed guidelines on compulsory licences By Editha R Hechanova & Hechanova Group January 20 2020
China apex court ruling will provide more patent consistency Novel decision outlines ambitious step that China’s supreme court is taking to make it more efficient to enforce patent rights By Karry Lai January 20 2020
Cannabis filers hash over FTO and future enforcement Counsel at Aphria, Cresco Labs, Aurora, Scientus Pharma and Canopy Growth say due diligence is becoming more important in their efforts to avoid infringement on copious new registrations, many of which are overly broa... By Patrick Wingrove January 16 2020
UK SPC ruling pushes patent drafting specificity Generics and innovator pharma companies welcome December’s SPC decision from a UK court, saying it further clarifies an uncertain regulation, but believe it will introduce prosecution challenges By Charlotte Kilpatrick January 16 2020
SEP remedy policy ‘reversal’ emboldens US patent owners Despite having little legal impact, the Department of Justice’s and USPTO’s new joint policy statement on remedies for standard essential patents has encouraged many businesses in their FRAND negotiations By Patrick Wingrove January 16 2020
AI inventorship denial not surprising but is step towards change In-house counsel from tech, automotive and pharmaceutical companies say it is business as usual after the EPO rejects AI inventor applications, but could be the start of long-term change to AI patent law By Charlotte Kilpatrick January 16 2020
Lawyers react to US plans to strengthen design patent enforcement In-house and private practice lawyers say that proposed legislation could help companies fight counterfeiters and enforce design patents, though others say the bill raises prior art concerns By Rani Mehta January 14 2020
BIP Asia: AI-related IP policies need more work globally Patentability and sufficiency of disclosure remain unsettled issues that IP owners and offices are grappling with, according to AIPPI and private practice speakers By Karry Lai January 13 2020
Maintain your network: tips on returning to work after parental leave An in-house lawyer at Barclays, a former in-house counsel and two private practice lawyers speak to Managing IP about returning to work after taking a break to raise a family and finding the balance between work and h... By Rani Mehta January 10 2020
SEP stakeholders want essentiality checks in 2020 to streamline negotiations In-house counsel say checks would be a good way to demonstrate that technologies are essential to a standard, but are not certain how they should be done or by which organisation By Patrick Wingrove January 09 2020
Looking ahead to 2020: Lawyers contemplate key US patent cases Practitioners say that there could be significant IP shake-ups from the US Supreme Court, but that reform from Congress is unlikely By Rani Mehta January 09 2020
In-house roundup: Fintech win worries financials; businesses look to 2020 essentiality ... Managing IP rounds up the latest news and analysis from in-house counsel By Patrick Wingrove January 09 2020
First patent win for bank puts financials on their toes A $200-million payment for USAA shows that financial companies are vulnerable to competitor patent claims and might need to build up their defensive portfolios, according to in-house counsel By Patrick Wingrove January 08 2020
IP practitioners mull judicial shake-up to ease recruitment crisis Survey respondents are not convinced that the England and Wales High Court has the resources to deal with future IP cases, yet lawyers and experts are divided on the best methods to improve recruitment By Max Walters January 08 2020
Managing IP’s most-read stories in December 2019 The reveal of our Top 50 in IP list, an important clarification in Amazon’s role in combating counterfeits and in-house tips on keeping a lid on IP costs were among the most-read stories in the final month of last year By Managing IP Correspondent January 07 2020
BIP Asia: Nationalism is killing innovation Asia heads of IP at Canon and Microsoft share the challenges of securing IP partnerships in an era of trade wars, data privacy paranoia and disruptive innovations By Karry Lai January 06 2020
Looking ahead to 2020: lawyers contemplate key cases Practitioners say that there could be significant IP shake-ups from the US Supreme Court, but that reform from Congress is unlikely By Rani Mehta January 03 2020
